Literature DB >> 19135695

West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier.

Saguna Verma1, Yeung Lo, Moti Chapagain, Stephanie Lum, Mukesh Kumar, Ulziijargal Gurjav, Haiyan Luo, Austin Nakatsuka, Vivek R Nerurkar.   

Abstract

Neurological complications such as inflammation, failure of the blood-brain barrier (BBB), and neuronal death contribute to the mortality and morbidity associated with WNV-induced meningitis. Compromised BBB indicates the ability of the virus to gain entry into the CNS via the BBB, however, the underlying mechanisms, and the specific cell types associated with WNV-CNS trafficking are not well understood. Brain microvascular endothelial cells, the main component of the BBB, represent a barrier to virus dissemination into the CNS and could play key role in WNV spread via hematogenous route. To investigate WNV entry into the CNS, we infected primary human brain microvascular endothelial (HBMVE) cells with the neurovirulent strain of WNV (NY99) and examined WNV replication kinetics together with the changes in the expressions of key tight junction proteins (TJP) and cell adhesion molecules (CAM). WNV infection of HBMVE cells was productive as analyzed by plaque assay and qRT-PCR, and did not induce cytopathic effect. Increased mRNA and protein expressions of TJP (claudin-1) and CAM (vascular cell adhesion molecule and E-selectin) were observed at days 2 and 3 after infection, respectively, which coincided with the peak in WNV replication. Further, using an in vitro BBB model comprised of HBMVE cells, we demonstrate that cell-free WNV can cross the BBB, without compromising the BBB integrity. These data suggest that infection of HBMVE cells can facilitate entry of cell-free virus into the CNS without disturbing the BBB, and increased CAM may assist in the trafficking of WNV-infected immune cells into the CNS, via 'Trojan horse' mechanism, thereby contributing to WNV dissemination in the CNS and associated pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135695      PMCID: PMC2684466          DOI: 10.1016/j.virol.2008.11.047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

1.  Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East.

Authors:  Robert S Lanciotti; Gregory D Ebel; Vincent Deubel; Amy J Kerst; Severine Murri; Richard Meyer; Michael Bowen; Nancy McKinney; William E Morrill; Mary B Crabtree; Laura D Kramer; John T Roehrig
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

2.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Traversal of Candida albicans across human blood-brain barrier in vitro.

Authors:  A Y Jong; M F Stins; S H Huang; S H Chen; K S Kim
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.

Authors:  I Jordan; T Briese; N Fischer; J Y Lau; W I Lipkin
Journal:  J Infect Dis       Date:  2000-08-22       Impact factor: 5.226

5.  HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.

Authors:  Ibolya E András; Hong Pu; Mária A Deli; Avindra Nath; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci Res       Date:  2003-10-15       Impact factor: 4.164

Review 6.  Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.

Authors:  William A Muller
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

Review 7.  Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Erin Mehlhop; Elizabeth Sitati; Michael Engle
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

8.  Infection and injury of neurons by West Nile encephalitis virus.

Authors:  Bimmi Shrestha; David Gottlieb; Michael S Diamond
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 9.  Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta.

Authors:  C Avolio; F Giuliani; G M Liuzzi; M Ruggieri; D Paolicelli; P Riccio; P Livrea; M Trojano
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

10.  Experimental infection of horses with West Nile virus.

Authors:  Michel L Bunning; Richard A Bowen; C Bruce Cropp; Kevin G Sullivan; Brent S Davis; Nicholas Komar; Marvin S Godsey; Dale Baker; Danielle L Hettler; Derek A Holmes; Brad J Biggerstaff; Carl J Mitchell
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

View more
  112 in total

1.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

Review 2.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 3.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

4.  Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines.

Authors:  James F Kelley; Pakieli H Kaufusi; Esther M Volper; Vivek R Nerurkar
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

5.  Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.

Authors:  Matthew D Cain; Hamid Salimi; Yongfeng Gong; Lihua Yang; Samantha L Hamilton; James R Heffernan; Jianghui Hou; Mark J Miller; Robyn S Klein
Journal:  J Neuroimmunol       Date:  2017-05-01       Impact factor: 3.478

Review 6.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

7.  Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.

Authors:  Fang Li; Yueyun Wang; Lan Yu; Shengbo Cao; Ke Wang; Jiaolong Yuan; Chong Wang; Kunlun Wang; Min Cui; Zhen F Fu
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

8.  Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein.

Authors:  Rie Hasebe; Tadaki Suzuki; Yoshinori Makino; Manabu Igarashi; Satoko Yamanouchi; Akihiko Maeda; Motohiro Horiuchi; Hirofumi Sawa; Takashi Kimura
Journal:  BMC Microbiol       Date:  2010-06-08       Impact factor: 3.605

9.  Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death.

Authors:  Mukesh Kumar; Saguna Verma; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2010-10-31       Impact factor: 8.322

10.  IL-10 signaling blockade controls murine West Nile virus infection.

Authors:  Fengwei Bai; Terrence Town; Feng Qian; Penghua Wang; Masahito Kamanaka; Tarah M Connolly; David Gate; Ruth R Montgomery; Richard A Flavell; Erol Fikrig
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.